Symptoms of peripheral arterial disease: ramipril
KEYWORDS: walking, ramipril, disease, people, ahimastos, peripheral, arterial, arterial disease, peripheral arterial, reported, intermittent, intermittent claudication, claudication, evidence, summary

pain-free walking disturbances, rash, muscle spasms, myalgia, time (Ahimastos et al. 2006, hyperkalaemia, hypotension, syncope, chest n=40; both p<0.001; clinical pain and fatigue. importance unclear) • No adverse effects were reported the study by • mean maximum walking Ahimastos et al. (2006). In Shahin et al. distance and mean pain-free (2013a), the adverse effect most often walking distance (Shahin et al. reported with ramipril was cough, which led to 2013a, n=33; both p=0.001; discontinuation in some cases. clinical importance unclear). Patient factors Resource implications • Renal function should be • The cost of 28 days' treatment with ramipril assessed before and during 10 mg is £1.28 for capsules, £1.32 for tablets ramipril treatment, particularly and £358.40 for 2.5 mg/5 ml oral solution in people with renal impairment. (Drug Tariff, October 2015). • The results of the studies may not be generalisable to people with certain comorbid conditions (for example, disease limiting mobility or renal impairment). • Most of the participants in the studies were white and it is known that ACE inhibitors are less effective for treating hypertension in people of African or Caribbean family origin; therefore, the studies may not apply to this population. • It is not known
